MichaelRYorkMD

PubMed

• 4 citations
  Understanding Stakeholders' Perspectives to Increase COVID-19 Vaccine and Booster Uptake Among Black Individuals With Rheumatic Conditions.
  Nnenna Ezeh, Greta Sirek, Sciaska N Ulysse, Jessica N Williams, Mia T Chandler, Bisola O Ojikutu, Michael York, Monica Crespo-Bosque, Muriel Jean-Jacques, Tonya Robers...> ;Arthritis Care & Research. 2023 Dec 1
• 11 citations
  Innate Immune Modulation Induced by EBV Lytic Infection Promotes Endothelial Cell Inflammation and Vascular Injury in Scleroderma.
  Antonella Farina, Edoardo Rosato, Michael York, Benjamin E. Gewurz, Maria Trojanowska, Giuseppina Farina> ;Frontiers in Immunology. 2021 Jan 1
• 14 citations
  Lupus-Associated Immune Complexes Activate Human Neutrophils in an FcγRIIA-Dependent but TLR-Independent Response.
  Ramon G. Bonegio, Jessica Lin, Britte C. Beaudette-Zlatanova, Michael York, Hanni Menn-Josephy, Kei Yasuda> ;Journal of Immunology. 2019 Jan 4
• 45 citations
  Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
  Antonella Farina, Giovanna Peruzzi, Valentina Lacconi, Stefania Lenna, Silvia Quarta, Edoardo Rosato, Annarita Vestri, Michael York, David H. Dreyfus, Alberto Faggioni...> ;Arthritis Research & Therapy. 2017 Feb 28
• 225 citations
  Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
  Lisa M. Rice, Cristina Padilla, Sarah R. McLaughlin, Allison L. Mathes, Jessica Ziemek, Salma Goummih, Sashidhar Nakerakanti, Michael York, Giuseppina Farina, Michael ...> ;The Journal of Clinical Investigation. 2015 Jul 1
• 72 citations
  Epstein–Barr Virus Infection Induces Aberrant TLR Activation Pathway and Fibroblast–Myofibroblast Conversion in Scleroderma
  Antonella Farina, Mara Cirone, Michael York, Stefania Lenna, Cristina Padilla, Sarah R. McLaughlin, Alberto Faggioni, Robert Lafyatis, Maria Trojanowska, Giuseppina Fa...> ;The Journal of Investigative Dermatology. 2014 Apr 1
• 294 citations
  Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
  L. van Bon, Alsya J. Affandi, J. Broen, Romy B. Christmann, Renoud J. Marijnissen, Lukasz Stawski, Giuseppina Farina, Giuseppina Stifano, Allison L. Mathes, Marta Coss...> ;The New England Journal of Medicine. 2014 Jan 29
• 21 citations
  Ultrasound assessment of subcutaneous compressibility: a potential adjunctive diagnostic tool in eosinophilic fasciitis.
  Eugene Y. Kissin, Amit Garg, Peter C. Grayson, Maureen Dubreuil, Diana Vradii, Michael York, Robert W. Simms> ;Journal of Clinical Rheumatology. 2013 Oct 1
• 16 citations
  Pulmonary hypertension: screening and evaluation in scleroderma
  Michael York, Harrison W. Farber> ;Current Opinion in Rheumatology. 2011 Nov 1
• 18 citations
  Novel insights on the role of the innate immune system in systemic sclerosis.
  Michael York> ;Expert Review of Clinical Immunology. 2011 Jul 1
• 5 citations
  A woman with severe lupus nephritis and difficult to control diabetes mellitus
  Irina Buhaescu, Soo S. Rhee, Michael York, Marie E. McDonnell, Peter A. Merkel> ;Arthritis Care & Research. 2011 Apr 1
• 31 citations
  dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts
  Giuseppina Farina, Michael York, Cindy Collins, Robert Lafyatis> ;Annals of the Rheumatic Diseases. 2011 Mar 1
• 105 citations
  Poly(I:C) drives type I IFN- and TGFβ-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis.
  Giuseppina Farina, Michael York, Mike Di Marzio, Cindy Collins, Stephan Meller, Bernhard Homey, Ian R. Rifkin, Ann Marshak-Rothstein, Timothy R D J Radstake, Robert La...> ;The Journal of Investigative Dermatology. 2010 Nov 1
• 49 citations
  Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis.
  L. van Bon, Calin D. Popa, Richard Huijbens, Madelon C. Vonk, Michael York, Robert W. Simms, Roger Hesselstrand, Dirk M. Wuttge, Robert Lafyatis, Timothy R D J Radstake> ;Annals of the Rheumatic Diseases. 2010 Aug 1
• 61 citations
  Innate immunity and inflammation in systemic sclerosis.
  Robert Lafyatis, Michael York> ;Current Opinion in Rheumatology. 2009 Nov 1
• 198 citations
  B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis
  Robert Lafyatis, Eugene Y. Kissin, Michael York, Giuseppina Farina, Kerry Viger, Marvin J. Fritzler, Peter A. Merkel, Robert W. Simms> ;Arthritis and Rheumatism. 2009 Feb 1
• 231 citations
  A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agoni...
  Michael York, Taro Nagai, Alyson J. Mangini, Raphael Lemaire, Jean Maguire van Seventer, Robert Lafyatis> ;Arthritis and Rheumatism. 2007 Mar 1
• 97 citations
  Antimalarial Agents: Closing the Gate on Toll-like Receptors?
  Robert Lafyatis, Michael York, Ann Marshak-Rothstein> ;Arthritis and Rheumatism. 2006 Oct 1
• 67 citations
  Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study.
  David J. Hunter, Michael York, Christine E. Chaisson, Ryan Woods, Jingbo Niu, Yuqing Zhang> ;The Journal of Rheumatology. 2006 Jul 1
• Initial combination therapy with prednisone or infliximab improved outcomes in early rheumatoid arthritis more than DMARDs alone.
  Michael York, David J. Hunter> ;ACP Journal Club. 2006 May 1
• 43 citations
  Localization of the Binding Site on Intercellular Adhesion Molecule-3 (ICAM-3) for Lymphocyte Function-associated Antigen 1 (LFA-1)*
  Lloyd B. Klickstein, Michael R. York, Antonin de Fougerolles, Timothy A. Springer> ;The Journal of Biological Chemistry. 1996 Sep 27
• Characterization of lymphocyte function-associated antigen 1 (LFA-1)-deficient T cell lines: the alphaL and beta2 subunits are interdependent for cell surface expression.
  Weber, K. S., York, M. R., Springer, T. A., Klickstein, L. B.> ;J Immunol. 1997 Jan 1
• Join now to see all